Sunman-Birdem Pharma
SUNMAN-BIRDEM Pharma Ltd. is a pharmaceutical company established in 1975, operating a state-of-the-art manufacturing facility compliant with UK MHRA and US FDA guidelines. It is a joint venture between SUNMAN Group and the Diabetic Association of Bangladesh (BADAS), with a mission to make high-quality healthcare products affordable and accessible. The company produces bioequivalent medicines meeting international standards, with active ingredients sourced mainly from Europe. SUNMAN-BIRDEM aims to innovate in healthcare and improve lives through quality and affordable medicines.
Industries
Nr. of Employees
large (251-1000)
Sunman-Birdem Pharma
12TH FLOOR, TROPICAL MOLLA TOWER, 15/1-15/4 PROGOTI SHARANI, BIR UTTAM RAFIQUL ISLAM AVENUE, MID-BADDA, DHAKA-1212
Products
Aceclofenac (oral)
Oral analgesic formulation (nonsteroidal anti-inflammatory drug) for treatment of pain and inflammation.
Amlodipine Besylate (oral)
Oral antihypertensive formulation used to manage high blood pressure.
Atorvastatin Calcium (oral)
Oral lipid‑lowering statin formulation for management of hyperlipidemia.
Metformin Hydrochloride + Sitagliptin (oral)
Combination oral antidiabetic formulation for glucose control in type 2 diabetes.
Paracetamol + Caffeine (oral)
Oral analgesic combination product for fever and pain relief.
Aceclofenac (oral)
Oral analgesic formulation (nonsteroidal anti-inflammatory drug) for treatment of pain and inflammation.
Amlodipine Besylate (oral)
Oral antihypertensive formulation used to manage high blood pressure.
Atorvastatin Calcium (oral)
Oral lipid‑lowering statin formulation for management of hyperlipidemia.
Metformin Hydrochloride + Sitagliptin (oral)
Combination oral antidiabetic formulation for glucose control in type 2 diabetes.
Paracetamol + Caffeine (oral)
Oral analgesic combination product for fever and pain relief.
Services
On-site manufacture of oral solid dosage pharmaceuticals in a cGMP-compliant facility.
Development of generic formulations designed to be bioequivalent to originator products.
In-house QC testing and release testing using equipment matched to current cGMP expectations.
On-site manufacture of oral solid dosage pharmaceuticals in a cGMP-compliant facility.
Development of generic formulations designed to be bioequivalent to originator products.
In-house QC testing and release testing using equipment matched to current cGMP expectations.
Expertise Areas
- Pharmaceutical manufacturing (cGMP)
- Formulation development for oral solid dosage forms
- Generic drug production and portfolio management
- Quality control and analytical testing
Key Technologies
- cGMP-compliant manufacturing
- Oral solid dosage formulation
- Analytical QC instrumentation
- SOP-based quality systems
News & Updates
Resource Limit Is Reached
The website is temporarily unable to service your request as it exceeded resource limit.
Contrary to popular belief, Lorem Ipsum has roots in classical Latin literature from 45 BC.
Lorem Ipsum is used because it has a normal distribution of letters, making it look like readable English.
Lorem Ipsum is dummy text of the printing industry, used as standard dummy text since the 1500s.
Resource Limit Is Reached
The website is temporarily unable to service your request as it exceeded resource limit.
Contrary to popular belief, Lorem Ipsum has roots in classical Latin literature from 45 BC.
Lorem Ipsum is used because it has a normal distribution of letters, making it look like readable English.
Lorem Ipsum is dummy text of the printing industry, used as standard dummy text since the 1500s.